{A figure is presented}Predictors of Clinical Response to Gluten-Free Diet in Patients Diagnosed With Diarrhea-Predominant Irritable Bowel Syndrome

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 7, 2007, Pages 844-850

  Wahnschaffe, Ulrich ^a   Schulzke, Jörg Dieter ^b   Zeitz, Martin ^b   Ullrich, Reiner ^b  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN; HLA DQ2 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; ANTIIDIOTYPIC ANTIBODY; GLUTEN; HLA DQ ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE TRANSGLUTAMINASE 2, HUMAN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIARRHEA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PROTEIN EXPRESSION; CELIAC DISEASE; DIET THERAPY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; PROGNOSIS; PROTEIN RESTRICTION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTI-IDIOTYPIC; CELIAC DISEASE; DIARRHEA; DIET, PROTEIN-RESTRICTED; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GLIADIN; GLUTEN; HLA-DQ ANTIGENS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSGLUTAMINASES;

EID: 34447099633     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.03.021     Document Type: Article

References (32)

1. Green P.H., and Jabri B. Coeliac disease. Lancet 362 (2003) 383-391
2. Alaedini A., and Green P.H. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 142 (2005) 289-298
3. Henker J., Losel A., Conrad K., et al. [Prevalence of asymptommatic coeliac disease in children and adults in the Dresden region of Germany]. Dtsch Med Wochenschr 127 (2002) 1511-1515
4. Fasano A., Berti I., Gerarduzzi T., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163 (2003) 286-292
5. Maki M., Mustalahti K., Kokkonen J., et al. Prevalence of celiac disease among children in Finland. N Engl J Med 348 (2003) 2517-2524
6. Catassi C., Fanciulli G., D'Appello A.R., et al. Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease. Scand J Gastroenterol 35 (2000) 732-736
7. Green P.H. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology 128 (2005) S74-S78
8. Kagnoff M.F. AGA Institute medical position statement on the diagnosis and management of celiac disease. Gastroenterology 131 (2006) 1977-1980
9. Rostom A., Murray J.A., and Kagnoff M.F. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 131 (2006) 1981-2002
10. Troncone R., Greco L., Mayer M., et al. Latent and potential coeliac disease. Acta Paediatr Suppl 412 (1996) 10-14
11. Ferguson A., Arranz E., and O'Mahony S. Clinical and pathological spectrum of coeliac disease: active, silent, latent, potential. Gut 34 (1993) 150-151
12. Loft D.E., Nwokolo C.U., and Ciclitira P.J. The diagnosis of gluten sensitivity and coeliac disease: the two are not mutually inclusive. Eur J Gastroenterol Hepatol 10 (1998) 911-913
13. Drossman D.A., Camilleri M., Mayer E.A., et al. AGA technical review on irritable bowel syndrome. Gastroenterology 123 (2002) 2108-2131
14. Wahnschaffe U., Ullrich R., Riecken E.O., et al. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 121 (2001) 1329-1338
15. Cataldo F., Lio D., Marino V., et al. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency: Working Groups on Celiac Disease of SIGEP and Club del Tenue. Gut 47 (2000) 366-369
16. Burgin-Wolff A., Gaze H., Hadziselimovic F., et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 66 (1991) 941-947
17. Thompson W.G., Longstreth G.F., Drossman D.A., et al. Functional bowel disorders and functional abdominal pain. Gut 45 Suppl 2 (1999) II43-II47
18. Walker-Smith J., Guandalini S., Schmitz J., et al. Revised criteria for diagnosis of coeliac disease: report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 65 (1990) 909-911
19. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102 (1992) 330-354
20. Rostami K., Kerckhaert J., Tiemessen R., et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 94 (1999) 888-894
21. Veldhuyzen van Zanten S.J., Tytgat K.M., Pollak P.T., et al. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis?. J Clin Epidemiol 46 (1993) 273-279
22. Dieterich W., Laag E., Schopper H., et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115 (1998) 1317-1321
23. Sulkanen S., Halttunen T., Laurila K., et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115 (1998) 1322-1328
24. Gomez J.C., Selvaggio G., Pizarro B., et al. Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study. Am J Gastroenterol 97 (2002) 2785-2790
25. Wahnschaffe U., Stockmann M., Daum S., et al. Intestinal antibodies against gliadin, tissue-transglutaminase, beta-lactoglobulin, and ovalbumin in patients with irritable bowel syndrome. Ann N Y Acad Sci 859 (1998) 280-284
26. Cremonini F., and Talley N.J. Diagnostic and therapeutic strategies in the irritable bowel syndrome. Minerva Med 95 (2004) 427-441
27. Tursi A., and Brandimarte G. The symptomatic and histologic response to a gluten-free diet in patients with borderline enteropathy. J Clin Gastroenterol 36 (2003) 13-17
28. Mein S.M., and Ladabaum U. Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis. Aliment Pharmacol Ther 19 (2004) 1199-1210
29. Tursi A., Brandimarte G., and Giorgetti G.M. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 36 (2003) 219-221
30. Spiegel B.M., DeRosa V.P., Gralnek I.M., et al. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 126 (2004) 1721-1732
31. Sanders D.S., Patel D., Stephenson T.J., et al. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 15 (2003) 407-413
32. Sanders D.S., Carter M.J., Hurlstone D.P., et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 358 (2001) 1504-1508